STOCK TITAN

Accolade, Inc. SEC Filings

ACCD NASDAQ

Welcome to our dedicated page for Accolade SEC filings (Ticker: ACCD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Accolade’s business lives at the intersection of technology and healthcare, so its SEC disclosures can feel like decoding two industries at once. Whether you’re tracking how many employers renewed navigation contracts or how virtual primary-care visits affect margins, the detail hides deep inside dozens of filings. That complexity is exactly why investors search for “Accolade SEC filings explained simply”—and it’s the problem this page solves.

Our AI dissects every submission the moment it posts to EDGAR, turning a 300-page Accolade annual report 10-K simplified into clear talking points. Looking for cash-flow impacts in the latest Accolade quarterly earnings report 10-Q filing? Want alerts on Accolade Form 4 insider transactions real-time before markets react? Stock Titan delivers. You’ll also find fast answers to common queries like “How do I read an Accolade proxy statement executive compensation section?” or “Which risk factors moved since last quarter?”

Every filing type is here, updated in real time: 8-K material events for partnership wins, S-8 share issuances tied to employee incentives, and of course Accolade insider trading Form 4 transactions that flag when executives buy or sell shares. Our AI-powered summaries spotlight member-growth metrics, cost-of-care assumptions, and revenue concentration data—insights professionals usually spend hours extracting. Use them to benchmark quarter-over-quarter trends, monitor regulatory shifts, or validate sentiment ahead of earnings calls. Understanding Accolade SEC documents with AI means you spend less time parsing jargon and more time making decisions.

Filing
Rhea-AI Summary

This Schedule 13G/A discloses that The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC jointly report beneficial ownership of Accolade, Inc. common stock totaling 65 shares. The cover pages show no sole voting or dispositive power, shared voting power of 44 and shared dispositive power of 65, and that the position represents 0.0% of the class and is held at the level of 5 percent or less. The filing includes a signed joint filing agreement authorizing each party to file amendments and an exhibit identifying Goldman Sachs & Co. LLC as a subsidiary broker/dealer and registered investment adviser of the GS Group. Item 10 certification states the holdings are held in the ordinary course of business and not to influence control.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

What is the current stock price of Accolade (ACCD)?

The current stock price of Accolade (ACCD) is $7.02 as of April 29, 2025.

What is the market cap of Accolade (ACCD)?

The market cap of Accolade (ACCD) is approximately 562.8M.
Accolade, Inc.

NASDAQ:ACCD

ACCD Rankings

ACCD Stock Data

562.77M
79.29M
All Other Information Services
Services-business Services, Nec
Link
US
PLYMOUTH MEETING